Navigation Links
23andMe and mondoBIOTECH Partner to Advance Research of Rare Diseases
Date:1/28/2009

ble information for identifying treatment protocols.

"We are eager to take an active role in advancing research of rare genetic disorders," said Linda Avey, co-founder of 23andMe. "By partnering with our colleagues at mondoBIOTECH, a company acutely focused in this area, we'll be able to leverage the genetics and bioinformatics expertise of our science team toward better understanding of these often devastating conditions."

"For years, we have been working on behalf of neglected and underserved disease communities to help improve the lives of people with rare and fatal diseases," said Fabio Cavalli, Chief Executive Officer of mondoBIOTECH. "When we met the founders of 23andMe last year at Davos and saw what they were doing with genetics, we knew that a collaboration between the two companies could go a long way towards understanding the causes of the diseases we have been researching."

About 23andMe

23andMe, Inc. is the leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service(TM) enables individuals to gain deeper insights into their ancestry and inherited traits. 23andMe, Inc., was founded by Linda Avey and Anne Wojcicki in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. Its Series A investors include Genentech, Inc., Google Inc. and New Enterprise Associates. More information is available at www.23andme.com

About mondoBIOTECH

mondoBIOTECH is the Swiss open source biotech aiming to improve the health of patients affected by rare diseases. mondoBIOTECH currently has a product pipeline of more than 300 peptides as treatment options for more than 600 rare diseases. The com
'/>"/>

SOURCE 23andMe, Inc.; mondoBIOTECH AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. 23andMe Announces Breast Cancer Initiative
2. The World Economic Forum Announces Technology Pioneers 2008: Mondobiotech Selected
3. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
6. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
9. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
11. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... and NEW YORK , ... PTBI, PTBIW), a biopharmaceutical company advancing patient care in ... offering of 3,500,000 shares of common stock, and warrants ... common stock, at an offering price of $4.00 per ... per share exercise price of $5.00, are exercisable immediately, ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 Earlier this ... James L. Sherley, director of the Adult Stem Cell ... an often overlooked and under appreciated unique property of ... by Distributed Stem Cells: Misunderstood in the Past, Important ... to congress participants. He gave the address at ...
(Date:12/24/2014)... Nashville, Tenn. (PRWEB) December 23, 2014 ... Hill was elected treasurer for the American Society ... to advancing knowledge and research in reproductive medicine. ... fills a seat on the executive board and will ... , Dr. Hill has actively supported ASRM since ...
(Date:12/24/2014)... December 23, 2014 PharmaBoardroom,s ... out today and available for free download , digs ... change and growth in the sector today. One ... successes has been in developing a homegrown pharmaceutical manufacturing base, ... production still remains some way off. A cursory comparison with ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3
... Mass., March 31 Boston Scientific,Corporation (NYSE: ... Scientific Santa,Rosa Corp., formerly known as TriVascular, Inc., ... in Santa Rosa, California. Boston Scientific,Santa Rosa Corp. ... endovascular aortic repair (EVAR) program. Terms of the ...
... ... Year-over-Year, ALISO VIEJO, Calif., ... and services resource for,pathologists, oncologists and the pharmaceutical industry, today announced,financial ... from continuing operations was $12.4 million for the fourth quarter,of 2007, ...
... poster ... presentations, SOUTH SAN FRANCISCO, Calif., March ... clinical,trials of the company,s investigational compounds XL647, XL184, XL765 and,XL880 will be ... will be held from May 30 to June 3, 2008 in,Chicago, Illinois. ...
Cached Biology Technology:Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program 2Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program 3Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 2Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 3Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 4Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 5Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 6Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 7Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 8Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 9Seven Abstracts Featuring Exelixis Compounds Accepted for Presentation at 2008 ASCO Annual Meeting 2
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today ... audit to confirm its adherence to current U.S. ... enables HITLAB to conduct regulated smart device and ... for patient safety and research quality. ... quality, and delivery with innovative technology," said ...
(Date:12/17/2014)... DUBLIN , Dec. 16, 2014 Research ... announced the addition of the "Global Chemical ... http://photos.prnewswire.com/prnh/20130307/600769 ... is the increasing demand for medical sensors in ... patient data for quick and correct diagnosis during ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... RIVERSIDE, Calif. Julia Bailey-Serres , a geneticist whose ... will give a free, public lecture at UC Riverside on ... challenge of improving crop yield in the face of climate ... Solutions," the hour-long lecture will begin at 7 p.m. in ...
... This press release is available in Spanish . ... calves has been developed by Agricultural Research Service (ARS) scientists who ... nutrient the young animals need to promote optimal growth and health. ... from their mothers as they nurse during the first few days ...
... discovered a defect in cellular pathways that provides a new ... newborns, known as craniosynostosis. Mutations of the WNT ... that regulate bone formation at the stem cell level, according ... Science Signaling . "Our work contributes to the ...
Cached Biology News:Public lecture to explore solutions to the food challenge 2Public lecture to explore solutions to the food challenge 3Model developed for manipulating vitamin D levels in calves 2Stem-cell disruption induces skull deformity, UR study shows 2
Mouse monoclonal [RL13] to LAP1 ( Abpromise for all tested applications). SwissProtID: Q96NW7...
CircuLex Anti-Human S100P Polyclonal Antibody Research Focus: proliferation Storage: -20C Shipping Temperature: 4C...
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide...
Biology Products: